Feasibility of smartphone-enabled asynchronous video directly observed therapy to improve viral suppression outcomes among HIV unsuppressed children and adolescents in Kenya

Abstract Background Video directly observed therapy (VDOT) has been used as an acceptable, cost-effective, client-centered intervention for tuberculosis management. VDOT targeting children (0–14 years) and adolescents (15–19 years) living with HIV (CALHIV) not achieving viral suppression (VS) [i.e.,...

Full description

Saved in:
Bibliographic Details
Main Authors: Paul Wekesa, Margaret Ndisha, Boniface Makone, Marc Bulterys, Evelyn Ngugi, Kevin Kamenwa, Abraham Katana, Kevin Owuor, Immaculate Mutisya
Format: Article
Language:English
Published: BMC 2025-04-01
Series:BMC Infectious Diseases
Subjects:
Online Access:https://doi.org/10.1186/s12879-025-11036-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850284505698402304
author Paul Wekesa
Margaret Ndisha
Boniface Makone
Marc Bulterys
Evelyn Ngugi
Kevin Kamenwa
Abraham Katana
Kevin Owuor
Immaculate Mutisya
author_facet Paul Wekesa
Margaret Ndisha
Boniface Makone
Marc Bulterys
Evelyn Ngugi
Kevin Kamenwa
Abraham Katana
Kevin Owuor
Immaculate Mutisya
author_sort Paul Wekesa
collection DOAJ
description Abstract Background Video directly observed therapy (VDOT) has been used as an acceptable, cost-effective, client-centered intervention for tuberculosis management. VDOT targeting children (0–14 years) and adolescents (15–19 years) living with HIV (CALHIV) not achieving viral suppression (VS) [i.e., < 1000 copies/ml] was piloted in 73 facilities in Kenya. We conducted a feasibility study on the utilization and re-suppression rates of clients enrolled in VDOT. Methods A review of data from 223 virally unsuppressed clients aged between 0–19 years on antiretroviral therapy (ART) who were enrolled to use the VDOT application daily for at least 12 weeks between February 2021 and October 2022 at 73 health facilities was conducted. Clients stopped using the application upon achieving VS. VS was assessed after at least 12 weeks of VDOT follow-up through self-care or healthcare worker (HCW)-led approaches. Using a multivariable Cox Proportional Hazards regression model, we assessed demographic and clinical determinants of VS presenting adjusted hazard ratios (aHR). Results Most users, 163 (73.1%) were adolescents aged 10–19 years. Only 19 (8.5%) were on self-care VDOT. Median time on follow-up was 19 weeks, with 126 videos uploaded, and 75% VDOT adherence. Over three-fourths, 176 (78.9%) had achieved VS during follow-up. Results showed a higher likelihood of VS among children on once-daily compared to twice-daily ARV dosage, aHR = 2.51 (95% CI: 2.06 – 3.05), and those on second- or third-line regimens compared to those on first-line regimens, aHR = 3.05 (95% CI: 1.78 – 5.22). Similarly, those on a DTG-based regimen had a higher likelihood of VS compared to those on LPV/r-based, ATV/s-based, or EFV-based regimens, aHR = 1.95 (95% CI: 1.25 – 3.06). Children receiving care from guardians and siblings had a higher likelihood of VS compared to those receiving care from parent caregivers, 1.61 (95% CI: 1.27—2.03), and 2.00 (95% CI: 1.12 – 3.57), respectively. Conclusion VDOT supported the achievement of VS among unsuppressed CALHIV on antiretroviral treatment and was significantly associated with dosage frequency, antiretroviral regimen, first- or second-line therapy, antiretroviral regimen classification, and type of caregiver. Findings suggest the utility of VDOT among unsuppressed CALHIV in resource-limited settings.
format Article
id doaj-art-dcf4251bad524fb7a010426b6814bf2e
institution OA Journals
issn 1471-2334
language English
publishDate 2025-04-01
publisher BMC
record_format Article
series BMC Infectious Diseases
spelling doaj-art-dcf4251bad524fb7a010426b6814bf2e2025-08-20T01:47:33ZengBMCBMC Infectious Diseases1471-23342025-04-0125111110.1186/s12879-025-11036-9Feasibility of smartphone-enabled asynchronous video directly observed therapy to improve viral suppression outcomes among HIV unsuppressed children and adolescents in KenyaPaul Wekesa0Margaret Ndisha1Boniface Makone2Marc Bulterys3Evelyn Ngugi4Kevin Kamenwa5Abraham Katana6Kevin Owuor7Immaculate Mutisya8Center for Health SolutionsDivision of Global HIV&TB (DGHT), Global Health Center, U.S. Centers for Disease Control and Prevention (CDC)Division of Global HIV&TB (DGHT), Global Health Center, U.S. Centers for Disease Control and Prevention (CDC)Division of Global HIV&TB (DGHT), Global Health Center, U.S. Centers for Disease Control and Prevention (CDC)Division of Global HIV&TB (DGHT), Global Health Center, U.S. Centers for Disease Control and Prevention (CDC)Center for Health SolutionsDivision of Global HIV&TB (DGHT), Global Health Center, U.S. Centers for Disease Control and Prevention (CDC)Center for Health SolutionsDivision of Global HIV&TB (DGHT), Global Health Center, U.S. Centers for Disease Control and Prevention (CDC)Abstract Background Video directly observed therapy (VDOT) has been used as an acceptable, cost-effective, client-centered intervention for tuberculosis management. VDOT targeting children (0–14 years) and adolescents (15–19 years) living with HIV (CALHIV) not achieving viral suppression (VS) [i.e., < 1000 copies/ml] was piloted in 73 facilities in Kenya. We conducted a feasibility study on the utilization and re-suppression rates of clients enrolled in VDOT. Methods A review of data from 223 virally unsuppressed clients aged between 0–19 years on antiretroviral therapy (ART) who were enrolled to use the VDOT application daily for at least 12 weeks between February 2021 and October 2022 at 73 health facilities was conducted. Clients stopped using the application upon achieving VS. VS was assessed after at least 12 weeks of VDOT follow-up through self-care or healthcare worker (HCW)-led approaches. Using a multivariable Cox Proportional Hazards regression model, we assessed demographic and clinical determinants of VS presenting adjusted hazard ratios (aHR). Results Most users, 163 (73.1%) were adolescents aged 10–19 years. Only 19 (8.5%) were on self-care VDOT. Median time on follow-up was 19 weeks, with 126 videos uploaded, and 75% VDOT adherence. Over three-fourths, 176 (78.9%) had achieved VS during follow-up. Results showed a higher likelihood of VS among children on once-daily compared to twice-daily ARV dosage, aHR = 2.51 (95% CI: 2.06 – 3.05), and those on second- or third-line regimens compared to those on first-line regimens, aHR = 3.05 (95% CI: 1.78 – 5.22). Similarly, those on a DTG-based regimen had a higher likelihood of VS compared to those on LPV/r-based, ATV/s-based, or EFV-based regimens, aHR = 1.95 (95% CI: 1.25 – 3.06). Children receiving care from guardians and siblings had a higher likelihood of VS compared to those receiving care from parent caregivers, 1.61 (95% CI: 1.27—2.03), and 2.00 (95% CI: 1.12 – 3.57), respectively. Conclusion VDOT supported the achievement of VS among unsuppressed CALHIV on antiretroviral treatment and was significantly associated with dosage frequency, antiretroviral regimen, first- or second-line therapy, antiretroviral regimen classification, and type of caregiver. Findings suggest the utility of VDOT among unsuppressed CALHIV in resource-limited settings.https://doi.org/10.1186/s12879-025-11036-9Children and adolescents living with HIVVideo directly observed therapy (VDOT)Viral suppressionKenyaAntiretroviral treatment
spellingShingle Paul Wekesa
Margaret Ndisha
Boniface Makone
Marc Bulterys
Evelyn Ngugi
Kevin Kamenwa
Abraham Katana
Kevin Owuor
Immaculate Mutisya
Feasibility of smartphone-enabled asynchronous video directly observed therapy to improve viral suppression outcomes among HIV unsuppressed children and adolescents in Kenya
BMC Infectious Diseases
Children and adolescents living with HIV
Video directly observed therapy (VDOT)
Viral suppression
Kenya
Antiretroviral treatment
title Feasibility of smartphone-enabled asynchronous video directly observed therapy to improve viral suppression outcomes among HIV unsuppressed children and adolescents in Kenya
title_full Feasibility of smartphone-enabled asynchronous video directly observed therapy to improve viral suppression outcomes among HIV unsuppressed children and adolescents in Kenya
title_fullStr Feasibility of smartphone-enabled asynchronous video directly observed therapy to improve viral suppression outcomes among HIV unsuppressed children and adolescents in Kenya
title_full_unstemmed Feasibility of smartphone-enabled asynchronous video directly observed therapy to improve viral suppression outcomes among HIV unsuppressed children and adolescents in Kenya
title_short Feasibility of smartphone-enabled asynchronous video directly observed therapy to improve viral suppression outcomes among HIV unsuppressed children and adolescents in Kenya
title_sort feasibility of smartphone enabled asynchronous video directly observed therapy to improve viral suppression outcomes among hiv unsuppressed children and adolescents in kenya
topic Children and adolescents living with HIV
Video directly observed therapy (VDOT)
Viral suppression
Kenya
Antiretroviral treatment
url https://doi.org/10.1186/s12879-025-11036-9
work_keys_str_mv AT paulwekesa feasibilityofsmartphoneenabledasynchronousvideodirectlyobservedtherapytoimproveviralsuppressionoutcomesamonghivunsuppressedchildrenandadolescentsinkenya
AT margaretndisha feasibilityofsmartphoneenabledasynchronousvideodirectlyobservedtherapytoimproveviralsuppressionoutcomesamonghivunsuppressedchildrenandadolescentsinkenya
AT bonifacemakone feasibilityofsmartphoneenabledasynchronousvideodirectlyobservedtherapytoimproveviralsuppressionoutcomesamonghivunsuppressedchildrenandadolescentsinkenya
AT marcbulterys feasibilityofsmartphoneenabledasynchronousvideodirectlyobservedtherapytoimproveviralsuppressionoutcomesamonghivunsuppressedchildrenandadolescentsinkenya
AT evelynngugi feasibilityofsmartphoneenabledasynchronousvideodirectlyobservedtherapytoimproveviralsuppressionoutcomesamonghivunsuppressedchildrenandadolescentsinkenya
AT kevinkamenwa feasibilityofsmartphoneenabledasynchronousvideodirectlyobservedtherapytoimproveviralsuppressionoutcomesamonghivunsuppressedchildrenandadolescentsinkenya
AT abrahamkatana feasibilityofsmartphoneenabledasynchronousvideodirectlyobservedtherapytoimproveviralsuppressionoutcomesamonghivunsuppressedchildrenandadolescentsinkenya
AT kevinowuor feasibilityofsmartphoneenabledasynchronousvideodirectlyobservedtherapytoimproveviralsuppressionoutcomesamonghivunsuppressedchildrenandadolescentsinkenya
AT immaculatemutisya feasibilityofsmartphoneenabledasynchronousvideodirectlyobservedtherapytoimproveviralsuppressionoutcomesamonghivunsuppressedchildrenandadolescentsinkenya